Skip to main content
Article
Disease-Specific Self-Efficacy in Spasmodic Dysphonia Patients
Otolaryngology-Head and Neck Surgery
  • Amanda Hu, Drexel University
  • Derek D. Isetti, University of the Pacific
  • Allen D. Hillel, University of Washington
  • Patricia Waugh, University of Washington
  • Tanya K. Meyer, University of Washington
Document Type
Article
DOI
10.1177/0194599812472319
Publication Date
1-8-2013
Abstract
Objective. Self-efficacy (SE) is an optimistic self-belief that one can perform a novel task. This concept involves empowerment, self-esteem, and adaptation to a stressful situation. SE is a strong predictor of health behaviors. Our objectives were to study SE in spasmodic dysphonia (SD) and to develop a disease-specific SE-SD scale. Study Design. Prospective study. Setting. Academic hospital. Subject and Methods. Disease-specific SE-SD items were developed with laryngologists, speech pathologists, and SD patients. These items, General SE Scale, Voice Handicap Index-10 (VHI-10), Consensus Auditory Perceptual Evaluation of Voice (CAPE-V), and Hospital Anxiety and Depression Scale (HADS), were administered to SD patients who presented for botulinum toxin injections. Results. One hundred forty-five SD patients (mean age 59.5 6 13.6 years) had a general SE score (Cronbach’s a = 0.894) of 33.4 6 5.2 out of 40. This was negatively correlated with HADS-A (r = 20.42, P \ 0.001) and HADS-D (r = 20.42, P \ .001), but not correlated with VHI-10 (r = 20.098, P = .243) and CAPE-V (r = 20.047, P = .57). Factor analysis selected 8 items from the general SE scale and 5 disease-specific SE-SD items to generate a 13-item disease-specific SE-SD scale (Cronbach’s a = 0.907). Disease-specific SE-SD score was 42.1 6 6.9 out of 52 and was negatively correlated with VHI-10 (r = 20.19, P = .005), HADS-A (r = 20.43, P \.001), and HADS-D (r = 20.57, P \ .001), but not correlated with CAPE-V (r = 20.024, P = .60). Conclusion. SD patients established on botulinum toxin injections have high degrees of general and disease-specific SE. Patients with higher SE-SD demonstrate lower vocal handicap and lower levels of anxiety and depression. A 13-item disease-specific SE-SD scale has been developed.
Citation Information
Amanda Hu, Derek D. Isetti, Allen D. Hillel, Patricia Waugh, et al.. "Disease-Specific Self-Efficacy in Spasmodic Dysphonia Patients" Otolaryngology-Head and Neck Surgery Vol. 148 Iss. 3 (2013) p. 450 - 455 ISSN: 0194-5998
Available at: http://works.bepress.com/derek-isetti/3/